Summary

This system card describes ThetaMap AI at a high level for transparency. It avoids proprietary, patented, or trade‑secret information.

Intended Use & Context

Data & Privacy (High‑Level)

Risks & Safeguards (Non‑Exhaustive)

Potential Risks
  • Misinterpretation of summaries without context.
  • Use outside intended scope (e.g., clinical or eligibility decisions).
  • Data misuse if organizational controls are weak.
Safeguards
  • Clear non‑clinical boundary and intended‑use statements.
  • Layered consent and user notices; changelog for transparency.
  • Governance processes and security controls maintained by the operator.

Evaluation Overview

Evaluation is documented at an aggregate level to avoid revealing implementation specifics. Public materials summarize methodology and limitations without publishing proprietary internals.

Monitoring & Updates

Document History

DateChange
2025‑09‑14Initial publication of high‑level system card.